https://www.selleckchem.com/products/azd-1208.html
g speech, executive function, etc.) significantly correlated with inability to return to work at 12 and 24 months as well as poor outcome assessed by the extended Glasgow Outcome Scale (GOSE) at 3, 12 and 24 months. The number of patients with favorable outcomes significantly increased from 25.5% at discharge to 56.5 and 57.1% at 3 and 12 months, respectively, and further increased to 74.1% after 24 months. The NAB-S can be administered to the majority of patients with aSAH and can effectively detect clinically relevant neuropsychologi
Like
Comment
Share
